Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
Investigation of the outcome of an adjuvant treatment with catumaxomab as compared to surgery
alone in patients after curative resection of a gastric adenocarcinoma in order to gain more
detailed information primary on safety, tolerability and feasibility and secondary on
relevant efficacy parameters.